After a turbulent few weeks fueled by new U.S. tariff announcements, Wall Street has been anything but quiet and steady. But for retail investors? The dip has looked more like a discount.

U.S. stocks ticked higher Tuesday as markets continued their chaotic ride through the Trump administration’s latest tariff whiplash.

As the global demand for weight-loss drugs skyrockets, Amgen has unveiled a strategic push into the space with its once-monthly injectable candidate, MariTide.

Crown Castle has entered a critical transition phase, marked by the abrupt termination of CEO Steven Moskowitz and a major restructuring of its business model.

Harley-Davidson, the legendary American motorcycle manufacturer, is navigating a challenging chapter marked by declining sales, shifting leadership, and global trade tensions.

Apple's recent crisis has resulted from Trump’s decision to impose sweeping new tariffs on China and other countries, including a 125% duty on Chinese goods that impacts Apple’s China-centric supply chain.

Stocks are reeling this Thursday as Wall Street digests the escalation in the U.S.-China trade conflict.